These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7625116)

  • 1. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.
    Galletti R; Beauverger P; Wild TF
    Vaccine; 1995 Feb; 13(2):197-201. PubMed ID: 7625116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.
    Taylor J; Pincus S; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
    J Virol; 1991 Aug; 65(8):4263-74. PubMed ID: 1830113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
    Wild TF; Bernard A; Spehner D; Drillien R
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
    Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
    J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant vaccinia immunization in the presence of passively administered antibody.
    Johnson MP; Meitin CA; Bender BS; Small PA
    Vaccine; 1993; 11(6):665-9. PubMed ID: 8322491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein.
    Drillien R; Spehner D; Kirn A; Giraudon P; Buckland R; Wild F; Lecocq JP
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1252-6. PubMed ID: 3422488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
    Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
    Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.
    Taylor J; Weinberg R; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
    Virology; 1992 Mar; 187(1):321-8. PubMed ID: 1736535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
    Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
    J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus.
    Etchart N; Wild F; Kaiserlian D
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2471-8. PubMed ID: 8887480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
    Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
    J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
    Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
    Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens.
    Wild TF; Bernard A; Spehner D; Villeval D; Drillien R
    Vaccine; 1993; 11(4):438-44. PubMed ID: 8470428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents.
    Fooks AR; Jeevarajah D; Lee J; Warnes A; Niewiesk S; ter Meulen V; Stephenson JR; Clegg JC
    J Gen Virol; 1998 May; 79 ( Pt 5)():1027-31. PubMed ID: 9603317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
    Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
    J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
    Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD
    Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
    Weidinger G; Ohlmann M; Schlereth B; Sutter G; Niewiesk S
    Vaccine; 2001 Apr; 19(20-22):2764-8. PubMed ID: 11282186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of measles virus antigens in Streptococcus gordonii.
    Maggi T; Oggioni MR; Medaglini D; Bianchi Bandinelli ML; Soldateschi D; Wiesmüller KH; Muller CP; Valensin PE; Pozzi G
    New Microbiol; 2000 Apr; 23(2):119-28. PubMed ID: 10872681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.
    Schlereth B; Buonocore L; Tietz A; Meulen VT; Rose JK; Niewiesk S
    J Gen Virol; 2003 Aug; 84(Pt 8):2145-2151. PubMed ID: 12867646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.